Abstract
Targeted liposomes triggered by ultrasound are a promising drug delivery system as they potentially improve the clinical outcomes of chemotherapy while reducing associated side effects. In this work, a comprehensive model fitting was performed for a large dataset of liposomal release profiles with seven targeting moieties (albumin, cRGD, estrone, hyaluronic acid, Herceptin, lactobionic acid, and transferrin) in addition to the control liposomes under ultrasound release protocols. Two levels of ultrasound frequencies were tested: low frequency (20 kHz) at 6.2, 9, and 10 mW/cm2 as well as high frequencies (1.07 MHz and 3 MHz) at 10.5 and 173 W/cm2. At a low frequency, Hixson–Crowell, Korsmeyer–Peppas, Gompertz, Weibull, and Lu–Hagen showed good fits to our release profiles at all three power densities. At high frequencies, the former three models reflected the best fit. These models will aid in predicting drug release profiles for future in vitro studies.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference37 articles.
1. (2022, July 17). Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.
2. Brown, D.L. (2014). Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook, Oncology Nursing Society (ONS).
3. Molecular Mechanisms of Drug Resistance;Longley;J. Pathol.,2005
4. Combination Chemotherapy in the Treatment of Advanced Hodgkin’s Disease;Devita;Ann. Intern. Med.,1970
5. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin’s Lymphoma;Fisher;N. Engl. J. Med.,1993
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献